journal article·2026-04Open access

Cohort‐Scale Spatial Autocorrelation for Tumor Prediction in Mid‐Infrared Pathology and Spatial Biomarker Discovery Using MALDI Imaging Lipidomics

Miriam F. Rittel, Nikolas Ebert, Denis Abu Sammour, Sebastian Graf, Björn C. Fröhlich, Emrullah Birgin, Shad A. Mohammed, Nuh N. Rahbari, Axel Wellmann, Oliver Wasenmüller, Cleo‐Aron Weis, Stefan Schmidt, Carsten Hopf

Advanced Science· Volume 13· Issue 24

Abstract

ABSTRACT Mid‐infrared (MIR) imaging is an emerging label‐free modality for classifying tissue types, including viable tumor in highly heterogeneous cancers, by assessing spatial differences in chemical composition. However, common data analysis neglects spatial vicinity and relies on time‐consuming pathological insight for hotspot prediction of viable tumor areas and computational tissue type annotation. Here, we present a method that uses spatial autocorrelation on MIR projection images computed from data of selected wavenumbers found by random forest ranking for computational tissue type annotation: Interdependent data processing enabled high accuracy annotations, whereas referencing of sequentially added new samples to a hyperspectral tissue database ensured computational efficiency and scalability for larger cohorts. Applied to clinical colorectal cancer liver metastasis samples, the method matched manual pathology assessment in a double‐blind study. As an option, MIR‐based hotspots can be correlated with mass spectrometry imaging. This multimodal approach identified sphingomyelin isoforms as lipidomic tumor marker candidates by imaging parallel reaction monitoring‐parallel accumulation serial fragmentation (iprm‐PASEF) directly on tissue. Taken together, spatial autocorrelation analysis on MIR imaging data could improve automated accurate annotation of tissue morphologies of heterogeneous cancer specimens and support the discovery of spatial cancer biomarkers.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spectroscopy Techniques in Biomedical and Chemical Research · Mass Spectrometry Techniques and Applications · Metabolomics and Mass Spectrometry Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CeMOS Research and Transfer Center Mass Spectrometry and Optical Spectroscopy Technische Hochschule Mannheim Mannheim Germany

Medical Faculty Mannheim Heidelberg University Mannheim Germany

CeMOS Research and Transfer Center Intelligent Systems Technische Hochschule Mannheim Mannheim Germany

Institute of Pathology Heidelberg University Hospital Heidelberg Germany

German Cancer Research Center (DKFZ) Heidelberg Germany

Department of Surgery University Medical Centre Mannheim Mannheim Germany

Institute of Pathology Celle Germany

Interdisciplinary Center for Scientific Computing (IWR) Heidelberg University Heidelberg Germany

Medical Faculty Heidelberg Heidelberg University Heidelberg Germany

Funding

Deutsche Forschungsgemeinschaft

References (72)

Show source-provided references
1. 10.1016/j.jpha.2023.07.00310.1016/j.jpha.2023.07.003 ↗
2. 10.3389/fbinf.2023.115938110.3389/fbinf.2023.1159381 ↗
3. 10.1038/s41591‐023‐02504‐310.1038/s41591‐023‐02504‐3 ↗
4. 10.1038/s41591‐024‐02857‐310.1038/s41591‐024‐02857‐3 ↗
5. 10.1038/s41591‐024‐03141‐010.1038/s41591‐024‐03141‐0 ↗
6. 10.1016/j.heliyon.2025.e4211110.1016/j.heliyon.2025.e42111 ↗
7. 10.1016/j.mlwa.2024.10054910.1016/j.mlwa.2024.100549 ↗
8. 10.1186/s12859‐015‐0804‐910.1186/s12859‐015‐0804‐9 ↗
9. 10.1038/s41598‐021‐90777‐410.1038/s41598‐021‐90777‐4 ↗
10. 10.1146/annurev‐anchem‐101422‐09095610.1146/annurev‐anchem‐101422‐090956 ↗
11. 10.1038/s41467‐023‐40740‐w10.1038/s41467‐023‐40740‐w ↗
12. 10.1038/s41598‐018‐26098‐w10.1038/s41598‐018‐26098‐w ↗
13. 10.1021/acs.analchem.0c0498610.1021/acs.analchem.0c04986 ↗
14. 10.1007/s00418‐021‐02037‐110.1007/s00418‐021‐02037‐1 ↗
15. 10.1021/acs.analchem.8b0291310.1021/acs.analchem.8b02913 ↗
16. 10.3390/cancers1510267610.3390/cancers15102676 ↗
17. 10.1038/s41467‐025‐59839‐310.1038/s41467‐025‐59839‐3 ↗
18. 10.1016/j.talanta.2023.12551810.1016/j.talanta.2023.125518 ↗
19. 10.1021/acs.analchem.7b0033210.1021/acs.analchem.7b00332 ↗
20. 10.1038/s41598‐017‐18477‐610.1038/s41598‐017‐18477‐6 ↗
21. 10.3791/6870910.3791/68709 ↗
22. 10.1038/srep3000810.1038/srep30008 ↗
23. 10.1016/j.bbadis.2003.12.00610.1016/j.bbadis.2003.12.006 ↗
24. 10.7150/ijbs.8306810.7150/ijbs.83068 ↗
25. 10.1039/d5an00046g10.1039/d5an00046g ↗
26. 10.1038/s41588‐025‐02119‐z10.1038/s41588‐025‐02119‐z ↗
27. 10.1038/s41467‐023‐37394‐z10.1038/s41467‐023‐37394‐z ↗
28. 10.1021/acs.analchem.6b0067210.1021/acs.analchem.6b00672 ↗
29. 10.1101/gr.271288.12010.1101/gr.271288.120 ↗
30. 10.18632/oncotarget.438310.18632/oncotarget.4383 ↗
31. 10.1016/j.addr.2020.07.01310.1016/j.addr.2020.07.013 ↗
32. 10.3390/cancers1303047410.3390/cancers13030474 ↗
33. 10.1186/s12944‐024‐02121‐010.1186/s12944‐024‐02121‐0 ↗
34. 10.3390/ijms2514772210.3390/ijms25147722 ↗
35. 10.1039/d5mo00045a10.1039/d5mo00045a ↗
36. 10.20892/j.issn.2095‐3941.2025.006610.20892/j.issn.2095‐3941.2025.0066 ↗
37. 10.3390/cancers1601005910.3390/cancers16010059 ↗
38. 10.1016/j.plipres.2021.10114510.1016/j.plipres.2021.101145 ↗
39. 10.3389/fchem.2023.133281610.3389/fchem.2023.1332816 ↗
40. 10.1016/j.bbalip.2024.15956810.1016/j.bbalip.2024.159568 ↗
41. 10.1515/cclm‐2019‐085810.1515/cclm‐2019‐0858 ↗
42. 10.1002/mas.2180410.1002/mas.21804 ↗
43. 10.1038/s41467‐023‐43298‐910.1038/s41467‐023‐43298‐9 ↗
44. 10.1016/j.chemolab.2021.10440710.1016/j.chemolab.2021.104407 ↗
45. 10.1039/c4an01978d10.1039/c4an01978d ↗
46. 10.1016/j.biotechadv.2021.10773910.1016/j.biotechadv.2021.107739 ↗
47. 10.1038/s41598‐021‐93686‐810.1038/s41598‐021‐93686‐8 ↗
48. 10.1038/s41598‐020‐67052‐z10.1038/s41598‐020‐67052‐z ↗
49. 10.1039/c3an01022h10.1039/c3an01022h ↗
50. 10.1021/jp407308710.1021/jp4073087 ↗
51. 10.1007/s13361‐019‐02327‐y10.1007/s13361‐019‐02327‐y ↗
52. 10.1038/s41592‐024‐02185‐x10.1038/s41592‐024‐02185‐x ↗
53. 10.1093/bioinformatics/btp46010.1093/bioinformatics/btp460 ↗
54. 10.3390/ijms1812255010.3390/ijms18122550 ↗
55. 10.1053/j.gastro.2021.05.00910.1053/j.gastro.2021.05.009 ↗
56. 10.1007/s00424‐024‐02960‐x10.1007/s00424‐024‐02960‐x ↗
57. Anticancer Compounds and Sphingolipid Metabolism in the Colon
58. 10.1038/cddis.2017.13010.1038/cddis.2017.130 ↗
59. 10.3389/fonc.2023.132062110.3389/fonc.2023.1320621 ↗
60. 10.1007/s13361‐011‐0230‐910.1007/s13361‐011‐0230‐9 ↗
61. 10.1007/s00464‐016‐5121‐510.1007/s00464‐016‐5121‐5 ↗
62. 10.1126/scitranslmed.aan396810.1126/scitranslmed.aan3968 ↗
63. 10.1038/s41596‐019‐0217‐810.1038/s41596‐019‐0217‐8 ↗
64. 10.1038/nmeth.189610.1038/nmeth.1896 ↗
65. 10.1038/nprot.2014.11010.1038/nprot.2014.110 ↗
66. 10.1038/s41586‐020‐2649‐210.1038/s41586‐020‐2649‐2 ↗
67. 10.1038/s41592‐019‐0686‐210.1038/s41592‐019‐0686‐2 ↗
68. 10.1016/j.aca.2025.34427210.1016/j.aca.2025.344272 ↗
69. 10.1093/bioinformatics/bts44710.1093/bioinformatics/bts447 ↗
70. 10.7717/peerj.45310.7717/peerj.453 ↗
71. 10.1093/bioinformatics/btq04610.1093/bioinformatics/btq046 ↗
72. 10.1186/1471‐2105‐9‐30310.1186/1471‐2105‐9‐303 ↗